Iara Antonia Lustosa Nogueira

Iara Antonia Lustosa Nogueira

Auto-generated profile, based on publicly available information

Iara Antonia Lustosa Nogueira

Hospital Universitario

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2021 in International Journal of Inflammation
Verified
Journal Article
Open access
PDF file
GBGysllene M. C. Brito
Gysllene M. C. Brito
AFAndrea M. M. Fontenele
Andrea M. M. Fontenele
ECerika carneiro
erika carneiro
INIara Antonia L. Nogueira
Iara Antonia L. Nogueira
TCTamires Barradas Cavalcante
Tamires Barradas Cavalcante
NFNatalino Salgado Filho
Natalino Salgado Filho
Background. The Neutrophil-to-Lymphocyte Ratio (NLR) and the Platelet-to-Lymphocyte Ratio (PLR) are inflammatory biomarkers for several diseases, such as cancer and cardiovascular morbidities; however, there are currently few studies on kidney diseases. We aimed to evaluate nondialysis patients and determine the association of NLR and PLR with inflammation in these patients. Methods. A prospective cross-sectional study was conducted with 85 patients at different stages of chronic kidney disease (CKD), treated at the Kidney Disease Prevention Center of the University Hospital of the Federal University of Maranhão. This study included adult nondialysis patients diagnosed with CKD. The participants’ blood samples were collected for a high-sensitivity C-reactive protein (hs-CRP) test and blood count. They were divided into two groups according to the presence or absence of inflammation based on the hs-CRP value (<0.5 mg/dL). NLR and PLR were calculated based on the absolute number of neutrophils, lymphocytes, and platelets and were compared between them and with hs-CRP. Statistical analysis was performed using the Stata software, with the Shapiro–Wilk, Mann–Whitney, Spearman’s Correlation, and receiver operating characteristic curve tests. This study was approved by the local ethics committee. Results. The participants were categorized into two groups: with inflammation (n = 64) and without inflammation (n = 21). The mean age was 61.43 ± 14.63 y. The NLR and PLR values were significantly different between the groups with and without inflammation ( p = 0.045 and p = 0.004 , respectively). However, only PLR showed a significant positive correlation with hs-CRP ( p = 0.015 ). The best cutoff point for NLR to detect inflammation was 1.98, with 76.19% sensitivity and 48.44% specificity. For PLR, it was 116.07, with 85.71% sensitivity and 51.56% specificity. There was no significant difference between the area under the NLR and PLR curve (0.71 vs. 0.64; p = 0.186 ) for this population. Conclusions. This study showed that PLR was positively correlated with hs-CRP in nondialysis CKD patients and can be used to identify inflammation in this population.

4 September 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
INIara Antonia Lustosa Nogueira
Iara Antonia Lustosa Nogueira
ÉCÉrika Joseth Sousa Nogueira Da Cruz
Érika Joseth Sousa Nogueira Da Cruz
AFAndréa Martins Melo Fontenele
Andréa Martins Melo Fontenele
JNJosé Albuquerque De Figueiredo Neto
José Albuquerque De Figueiredo Neto
Menopause consists of a physiological process in women between 40 and 50 years of age, and it has substantial consequences for health, ranging from disturbances in lipid and glycidic metabolism to psychological stress and sleep alterations, thereby increasing women’s risk of cardiovascular diseases. Here, we attempted to identify potential lipid alterations not identified by the classic methods. We analyzed the serum lipid profile in 40 women in pre- and post-menopause using a lipidomic approach and mass spectrometry. Lipid species presented increased concentrations, with a difference of more than 25% post-menopause and with the ceramides (N.C23:0.Cer, N.C23:0(OH).Cer and N.C24:0(OH).Cer) standing out with a fold change of 1.68, 1.59, and 1.58, respectively. It was also observed that 14 metabolites presented a significant difference in the average concentrations between pre- and post-menopause, especially the ceramide species. Strong and positive correlations were identified between various metabolites and fasting glucose, glycated hemoglobin, total cholesterol, LDL, and triglycerides. Of note were the association ceramide (N.C10:0.Cer) and lysophosphatidylethanolamine (LPE.a.C18:0) between fasting glucose and glycated hemoglobin. This study detected lipid alterations, especially in ceramides, post-menopause, as well as correlations with glycidic and lipid markers, which may in the future be useful to investigate diseases associated with menopause.

20 September 2021 in Revista Brasileira de Ortopedia
Verified
Journal Article
Open access
PDF file
LVLeandra Marla Aires Travassos Viana
Leandra Marla Aires Travassos Viana
INIara Antônia Lustosa Nogueira
Iara Antônia Lustosa Nogueira
AFAndréa Martins Melo Fontenele
Andréa Martins Melo Fontenele
LOLiszt Palmeira de Oliveira
Liszt Palmeira de Oliveira
Objetivo Identificar o perfil de adesão à profilaxia medicamentosa de tromboembolismo em pacientes submetidos a cirurgias ortopédicas de artroplastia de joelho ou de quadril em hospital público. Métodos Estudo de coorte prospectivo, realizado no período de agosto de 2017 a setembro de 2018, com pacientes adultos que foram acompanhados desde a internação até o pós-operatório. Para medir a adesão, aplicou-se a Escala de Adesão Terapêutica de Morisky de oito itens. A quantificação do grau de adesão foi determinada segundo o resultado da soma de todas as respostas corretas: alta adesão (8 pontos), média adesão (6 a < 8 pontos), e baixa adesão (< 6 pontos). No presente estudo, foram divididos em altamente aderentes aqueles que tiveram alta adesão e parcialmente aderentes os pacientes que tiveram média ou baixa adesão. Resultados A análise da adesão mostrou que 73,0% dos pacientes foram altamente aderentes, enquanto 27,0% foram parcialmente aderentes à tromboprofilaxia. O anticoagulante prescrito na alta hospitalar foi o rivaroxabana, inibidor direto do fator Xa. Obtiveram maior adesão os pacientes que não necessitaram de reforço na orientação sobre a profilaxia durante o acompanhamento e, por conseguinte, relataram boa e ótima aceitação à profilaxia, embora estivessem polimedicados durante a alta hospitalar. Conclusão A análise dos dados obtidos permitiu concluir que os fatores que mais influenciaram na adesão foram os níveis de compreensão e aceitação dos pacientes quanto à profilaxia, a quantidade de medicamentos usada por dia pelo paciente, o custo do anticoagulante e o seu potencial em desenvolver reações adversas. Não houve suporte financeiro de fontes públicas, comerciais, ou sem fins lucrativos. * Trabalho desenvolvido no Hospital Universitário da Universidade Federal do Maranhão, São Luís, MA, Brasil Received: 10 March 2020 Accepted: 11 February 2021 Publication Date: 20 September 2021 (online) © 2021. Sociedade Brasileira de Ortopedia e Traumatologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/) Thieme Revinter Publicações Ltda. Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

15 March 2021 in Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde
Verified
Journal Article
Open access
PDF file
ÍLÍkaro M. Lima
Íkaro M. Lima
SVSamira B. Vidigal
Samira B. Vidigal
NLNathália M. Lima
Nathália M. Lima
DCDaniel A. Carvalho
Daniel A. Carvalho
ESElton Jonh Freitas Santos
Elton Jonh Freitas Santos
INIara A. Nogueira
Iara A. Nogueira
Objective: To evaluate the impact of the application of the FASTHUG-MAIDENS mnemonic by clinical pharmacists to optimize critically ill patients’ pharmacotherapy. Methods: Cross-sectional study performed on an adult intensive care unit of an University Hospital, between august and november 2019, where 155 patients were followed by three clinical pharmacists during hospital stay. Patients who stayed less than 24 hours in the hospital or whose stay was during weekends or holidays were excluded. The interventions were performed together with a multidisciplinary team using FASTHUG-MAIDENS, as well as technical analysis of medical prescription and patients’ clinical evaluation. The clinical evaluation included analysis of laboratory tests, nursing records and medical prescription, all registered in an institutional spreadsheet. The pharmaceutical interventions were registered in the pharmaceutical section of both physic and electronic medical records, and the data were later evaluated, classified, and submitted to descriptive analytical analysis. Results: 1.145 pharmaceutical interventions were performed, with an acceptance rate of 99,3%. The number of pharmaceutical interventions were increased by 104,4% with the application of the FASTHUG-MAIDENS mnemonic, compared to the period before the research. The main interventions performed were: inclusion of a drug (25,2%), exclusion of a drug (17,9%), dose adjustment (12,2%), change of the administration timetable to avoid intravenous incompatibility (11,4%), inclusion of infusion rate (7,3%), dilution adequacy (5,8%), inclusion of reconstitution (3,5%), microbiological culture request (3,4%), drug interaction monitoring (2,7%), adequacy of infusion rate (2,6%) and others (7,4%).Pharmaceutical interventions showed clinical (96,9%), preventive (99,3%) and economic (21,6%) impact. Conclusion: The application of the FASTHUG-MAIDENS mnemonic extended the pharmaceutical care to critically ill patients, enabling an accurate evaluation of the pharmacotherapy, clinically impacting critical patient care and reducing errors and adverse drug events.

3 May 2022 in Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde
Verified
Journal Article
Open access
PDF file
NLNathalia M. Lima
Nathalia M. Lima
ASAfonso C. Santos
Afonso C. Santos
GBGysllene M. Brito
Gysllene M. Brito
SCSoraya S. Coelho
Soraya S. Coelho
LVLeandra M. Viana
Leandra M. Viana
INIara A. Nogueira
Iara A. Nogueira
Objetivos: Avaliar o perfil de risco e medidas profiláticas para tromboembolismo venoso (TEV) de pacientes clínicos e cirúrgicos em unidade de terapia intensiva e a atuação do farmacêutico clínico na avaliação de risco e profilaxia de TEV. Método: Estudo transversal, em unidade de terapia intensiva (UTI) de um Hospital Universitário, onde foram coletados dados de 76 pacientes, clínicos e cirúrgicos, acompanhados por farmacêuticos clínicos durante os meses de setembro a dezembro de 2020. Pacientes admitidos aos finais de semana com internação inferior a 24-48h, pacientes pediátricos, gestantes ou aqueles que já estavam em tratamento terapêutico com anticoagulantes não foram incluídos no estudo. Os dados foram obtidos da análise de prescrição médica, história clínica e evolução farmacêutica contidas em prontuário eletrônico. A avaliação do perfil de risco foi realizada através dos Scores de Pádua, para pacientes clínicos, e Score de Caprini, para pacientes cirurgicos e a adequação de profilaxia para TEV avaliada segundo diretrizes da nona edição do American College of Chest Physicians. Resultados: 76 pacientes foram incluídos, dos quais 64,7% eram cirúrgicos e 35,3% clínicos. Do total de pacientes, 67 (88,3%) foram classificados como alto risco, destes 64,2% pacientes cirúrgicos e 35,8% clínicos. Quanto à profilaxia farmacológica para TEV, 44,7% dos pacientes avaliados não tinham quimioprofilaxia prescrita. Quanto à atuação clínica do farmacêutico, em 13,1% dos pacientes avaliados houve a necessidade de intervenção para a inclusão de profilaxia farmacológica, dos quais 13,4% apresentavam alto risco de TEV. Conclusões: Pacientes internados em UTI possuem risco elevado de desenvolver TEV. As medidas profiláticas para TEV ainda se mostram inadequadas tanto em pacientes cirúrgicos como em pacientes clínicos, evidenciando a importância da atuação do farmacêutico clínico no processo de avaliação e implementação de medidas profiláticas para esta condição.